BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6096378)

  • 1. Human proapolipoprotein A-II is cleaved following secretion from Hep G2 cells by a thiol protease.
    Gordon JI; Sims HF; Edelstein C; Scanu AM; Strauss AW
    J Biol Chem; 1984 Dec; 259(24):15556-63. PubMed ID: 6096378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular processing of proapolipoprotein A-II in Hep G2 cell cultures is mediated by a 54-kDa protease immunologically related to cathepsin B.
    Gordon JI; Sims HF; Edelstein C; Scanu AM; Strauss AW
    J Biol Chem; 1985 Nov; 260(27):14824-31. PubMed ID: 2414299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro conversion of proapoprotein A-I to apoprotein A-I. Partial characterization of an extracellular enzyme activity.
    Edelstein C; Gordon JI; Toscas K; Sims HF; Strauss AW; Scanu AM
    J Biol Chem; 1983 Oct; 258(19):11430-3. PubMed ID: 6311811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits.
    Saku K; Liu R; Ohkubo K; Bai H; Hirata K; Yamamoto K; Morimoto Y; Yamada K; Arakawa K
    Biochim Biophys Acta; 1993 Apr; 1167(3):257-63. PubMed ID: 8481386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of human preproapolipoprotein A-II.
    Gordon JI; Budelier KA; Sims HF; Edelstein C; Scanu AM; Strauss AW
    J Biol Chem; 1983 Nov; 258(22):14054-9. PubMed ID: 6315718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proapolipoprotein-converting enzymes and high-density lipoprotein early events in biogenesis.
    Scanu AM
    Am Heart J; 1987 Feb; 113(2 Pt 2):527-32. PubMed ID: 3544766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of deleting the propeptide from human preproapolipoprotein A-I on co-translational translocation and signal peptidase processing.
    Folz RJ; Gordon JI
    J Biol Chem; 1987 Dec; 262(35):17221-30. PubMed ID: 3316231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased proapolipoprotein A-I processing in liver disease: evidence for hepatic participation in proapolipoprotein A-I conversion.
    Isobe H; Sakai H; Satoh M; Sakamoto S; Koga S; Nawata H
    Clin Chim Acta; 1990 Aug; 189(3):303-11. PubMed ID: 2121392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat liver and small intestine produce proapolipoprotein A-I which is slowly processed to apolipoprotein A-I in the circulation.
    Sliwkowski MB; Windmueller HG
    J Biol Chem; 1984 May; 259(10):6459-65. PubMed ID: 6427215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies on origin and site of action of enzyme activity responsible for conversion of human proapoprotein A-I into apoprotein A-I.
    Kooistra T; van Hinsbergh V; Havekes L; Kempen HJ
    FEBS Lett; 1984 May; 170(1):109-13. PubMed ID: 6327370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration that the enzyme that converts precursor of apolipoprotein A-I to apolipoprotein A-I is secreted by the hepatocarcinoma cell line Hep G2.
    Edelstein C; Kaiser M; Piras G; Scanu AM
    Arch Biochem Biophys; 1988 Nov; 267(1):23-30. PubMed ID: 2848450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease.
    Gordon JI; Sims HF; Lentz SR; Edelstein C; Scanu AM; Strauss AW
    J Biol Chem; 1983 Mar; 258(6):4037-44. PubMed ID: 6300070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human apolipoprotein A-I. Post-translational modification by fatty acid acylation.
    Hoeg JM; Meng MS; Ronan R; Fairwell T; Brewer HB
    J Biol Chem; 1986 Mar; 261(9):3911-4. PubMed ID: 3005308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoforms of apolipoprotein A-II in human plasma and thoracic duct lymph. Identification of proapolipoprotein A-II and sialic acid-containing isoforms.
    Lackner KJ; Edge SB; Gregg RE; Hoeg JM; Brewer HB
    J Biol Chem; 1985 Jan; 260(2):703-6. PubMed ID: 2981844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and processing of human serum apolipoprotein AII in vitro and in Hep G2 cells.
    Stoffel W; Blau R; Burk M
    Biol Chem Hoppe Seyler; 1985 Feb; 366(2):173-9. PubMed ID: 2985098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of apo-A-I processing in cultured hepatocytes.
    Banerjee D; Grieninger G; Parkes JL; Mukherjee TK; Redman CM
    J Biol Chem; 1986 Jul; 261(21):9844-9. PubMed ID: 3090026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier.
    Bojanovski D; Gregg RE; Brewer HB
    J Biol Chem; 1984 May; 259(10):6049-51. PubMed ID: 6725246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
    Arrol S; Mackness MI; Durrington PN
    Atherosclerosis; 2000 Jun; 150(2):255-64. PubMed ID: 10856517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of human preapolipoprotein A-IV.
    Gordon JI; Bisgaier CL; Sims HF; Sachdev OP; Glickman RM; Strauss AW
    J Biol Chem; 1984 Jan; 259(1):468-74. PubMed ID: 6706947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis.
    Matsuura T; Koga S; Ibayashi H
    Gastroenterol Jpn; 1988 Aug; 23(4):394-400. PubMed ID: 2846400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.